Large-scale testing (Phase 3)UnknownNCT01654146What this trial is testingICON8: Weekly Chemotherapy in Ovarian CancerWho this might be right forOvarian Cancer Medical Research Council 1,485
Testing effectiveness (Phase 2)Study completedNCT00003670What this trial is testingHormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPrimary Peritoneal Cavity Cancer Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT01583322What this trial is testingVargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian CancerWho this might be right forOvarian Cancer ARCAGY/ GINECO GROUP 188
Not applicableStudy completedNCT04879953What this trial is testingEffect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric OriginWho this might be right forCarcinomatosis, Peritoneal Association Francaise de Chirurgie 46
Early research (Phase 1)Study completedNCT00616941What this trial is testingPhase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Ludwig Institute for Cancer Research 28
Large-scale testing (Phase 3)Ended earlyNCT02641639What this trial is testingFOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian CancerWho this might be right forPlatinum Resistant Ovarian Cancer Mateon Therapeutics 70
Not applicableLooking for participantsNCT04595929What this trial is testingOncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-Who this might be right forPeritoneal CarcinomatosisGastric Cancer St. Petersburg State Pavlov Medical University 304
Testing effectiveness (Phase 2)Ended earlyNCT00516841What this trial is testingA Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Neoplasms Facet Biotech 16
Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816666What this trial is testingTorvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerWho this might be right forPlatinum-sensitive Relapsed Epithelial Ovarian CancerPlatinum-sensitive Relapsed Fallopian Tube CancerPlatinum-sensitive Relapsed Primary Peritoneal Cancer AstraZeneca 600
Testing effectiveness (Phase 2)UnknownNCT03073694What this trial is testingComparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal CarcinomatosisWho this might be right forCancer, AppendicealColoRectal Cancer University of Kansas Medical Center 100
Not applicableStudy completedNCT03471572What this trial is testingStudy to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in IndiaWho this might be right forOvarian Cancer AstraZeneca 240
Testing effectiveness (Phase 2)Study completedNCT02324595What this trial is testingMinimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility StudyWho this might be right forStage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer Catholic University of the Sacred Heart 30
Not applicableStudy completedNCT05300789What this trial is testingMetachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer PatientsWho this might be right forPeritoneal CarcinomatosisColon Cancer Carlos Cerdán Santacruz 1,152
Testing effectiveness (Phase 2)Study completedNCT00017017What this trial is testingCT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01264432What this trial is testingVeliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerWho this might be right forAdult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more National Cancer Institute (NCI) 34
Not applicableLooking for participantsNCT06351475What this trial is testingEfficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal ChemotherapyWho this might be right forPeritoneal NeoplasmsHyperthermic Intraperitoneal ChemotherapyIntraoperative Care+2 more Assistance Publique - Hôpitaux de Paris 140
Not applicableStudy completedNCT01656044What this trial is testingNegative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface CancerWho this might be right forColon CancerPancreatic CancerPerioperative/Postoperative Complications+2 more Wake Forest University Health Sciences 375
Large-scale testing (Phase 3)Study completedNCT00976911What this trial is testingAURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian CancerWho this might be right forOvarian Cancer Hoffmann-La Roche 361
Large-scale testing (Phase 3)Looking for participantsNCT06824467What this trial is testingEvaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Who this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Cancer Merck Sharp & Dohme LLC 770